Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cinnamomum burmanii, commonly known as Indonesian cinnamon, has demonstrated antibacterial properties in several scientific studies, primarily in vitro. Essential oils and extracts from C. burmanii bark have shown inhibitory effects against various bacteria, including Escherichia coli, Staphylococcus aureus, and Bacillus subtilis. The antimicrobial activity is attributed mainly to cinnamaldehyde and other phenolic compounds present in the bark. Studies such as those published in peer-reviewed journals (e.g., Journal of Ethnopharmacology, Phytotherapy Research) report moderate to strong antibacterial activity, particularly in laboratory settings. However, most of this evidence comes from test tube experiments, and there is a lack of robust clinical trials in humans demonstrating efficacy for treating bacterial infections. Traditional medicine systems, including some Southeast Asian herbal practices, have used cinnamon species for infection, but C. burmanii specifically is not as prominent in historical texts as C. verum or C. cassia. Overall, while scientific studies support potential antibacterial effects, the evidence is preliminary, and clinical relevance remains unclear. Therefore, the scientific basis exists but is limited, and therapeutic use for bacterial infections should be approached cautiously until more human studies are available.

More about Cinnamomum burmanii
More about Infection (bacterial)

Other ingredients used for Infection (bacterial)

Other health conditions supported by Cinnamomum burmanii

Products containing Cinnamomum burmanii